Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing By: Philadelphia Business Journal via Business Journals September 16, 2022 at 11:35 AM EDT A Villanova-based biotech startup focus on heart disease gets a new CEO Read More >> Related Stocks: Harbor Disruptive Innovation ETF
